VMQ StocksFor the value investor looking to harness academic research in
an actively managed portfolio
Bits and BipsNewsletter delivering insights on linking traditional finance, macro trends and cryptocurrency opportunities to help investors build stronger, more diversified portfolios.
All premium products come with free basic membership.
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
As of Wednesday, May 20, Baird Medical Investment Holdings Limited’s BDMD share price has dipped by
6.10%, which has investors questioning if this is right time to buy.
As of Tuesday, May 19, Baird Medical Investment Holdings Limited’s BDMD share price has dipped by
5.23%, which has investors questioning if this is right time to buy.
As of Tuesday, May 05, Baird Medical Investment Holdings Limited’s BDMD share price has surged by
6.67%, which has investors questioning if this is right time to sell.
As of Monday, May 04, Baird Medical Investment Holdings Limited’s BDMD share price has surged by
5.03%, which has investors questioning if this is right time to sell.
As of Tuesday, July 15, Baird Medical Investment Holdings Limited’s BDMD share price has dipped by
5.12%, which has investors questioning if this is right time to buy.
Cynthia McLaughlin
Financial Summary
Share Statistics
BDMD
Industry Median
Percentile (All Stocks)
Market Cap (Mil)
$32.0
$334.8
13%
Shares Out (Mil)
29.2
41.7
37%
Institutional Ownership
1.9%
77.3%
4%
Float (Mil)
4.7
34.7
11%
Beta
-1.18
0.86
1%
Avg Daily Volume (000s)
34
266
25%
Price Change (52-week)
(49.0%)
60.7%
16%
Growth
BDMD
Industry Median
Percentile (All Stocks)
Sales (5yr)
4.4%
11.8%
33%
Net Income (5yr)
(42.4%)
(5.8%)
9%
EPS (5yr)
na
10.7%
na
Dividends (5yr)
0.0%
0.0%
0%
Cash Flow (5yr)
na
(16.1%)
na
Estimates
Qtrly
Current Fiscal Year
Next Fiscal Year
# of Estimates
na
na
na
Current EPS
na
na
na
Month Ago EPS
na
na
na
# Rev Up
na
na
na
# Rev Down
na
na
na
Three Months Ago EPS
na
na
na
Year/Year Chg
na
na
na
Financials
BDMD
Industry Median
Percentile (All Stocks)
Sales (TTM) (Mil)
$23
$152
14%
Net Income (TTM) (Mil)
($27)
($11)
21%
EPS (TTM)
($0.981)
($0.500)
22%
Operating Cash Flow (TTM) (Mil)
($1)
($2)
30%
Net Cash Flow (TTM) (Mil)
($2)
$1
37%
Long-Term Debt (Q1) (Mil)
$6
$22
26%
Enterprise Value (Q1) (Mil)
$53
$304
16%
Valuation
BDMD
Industry Median
Percentile (All Stocks)
P/B
0.68
2.88
13%
P/E
na
30.5
na
Dividend Yield
0.0%
0.0%
0%
PEG (5yr hist)
na
1.9
na
Ratios
BDMD
Industry Median
Percentile (All Stocks)
Gross Margin
83.8%
59.1%
91%
Net Margin
(121.0%)
(7.7%)
7%
ROA
(36.9%)
(13.7%)
15%
ROE
(76.8%)
(15.9%)
12%
Liabilities to Assets
55.2%
44.9%
48%
F-Score
1
4
1%
Baird Medical Investment Holdings Limited did not pass any screens on 7/30/2026.
Looking for access to this powerful feature? Take the first step in becoming an A+ Investor today.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors